Institutional investors hold a majority ownership of AMGN through the 81.45% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2016, these large investors purchased a net $10.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO ASSET MANAGEMENT CORP. Bought 469.0 Thousand shares of Amgen
LYXOR INTERNATIONAL ASSET MANAGE... Bought 370.9 Thousand shares of Amgen
VANGUARD INVESTMENTS AUSTRALIA L... Bought 200.5 Thousand shares of Amgen